Deborah Schrag is the Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center. She currently holds the George H. Bosl Chair. She is a medical oncologist known for her work in patient care and examination of patient outcomes.

Deborah Schrag
NationalityAmerican
CitizenshipAmerican
SpouseYochai Benkler[1]
Scientific career
Institutions

Education and career

edit

Schrag received her undergraduate degree from Harvard University where she studied the history of science. She has an M.D. from Columbia University Medical School and an M.P.H. from Harvard University's School of Public Health. She has worked at Memorial Sloan Kettering Cancer Center and the Dana–Farber Cancer Institute. In 2021 she was named chair of the department of medicine at Memorial Sloan Kettering,[2] and as of 2024 she is the George H. Bosl Chair at Memorial Sloan Kettering Cancer Center.[3]

Research

edit

Schrag is noted for her work in comparing the efficacy of treatments for different forms of cancer. She has examined how the timing of surgery impacts patient outcomes for women with a mutation in a BRCA gene.[4][5] She led a research trial that examined the necessity of radiation therapy for rectal cancer patients.[6][7]

Selected publications

edit
  • Schrag, Deborah; Kuntz, Karen M.; Garber, Judy E.; Weeks, Jane C. (1997-05-15). "Decision Analysis — Effects of Prophylactic Mastectomy and Oophorectomy on Life Expectancy among Women with BRCA1 or BRCA2 Mutations". New England Journal of Medicine. 336 (20): 1465–1471. doi:10.1056/NEJM199705153362022. ISSN 0028-4793. PMID 9148160.
  • Schrag, Deborah (2000-12-20). "Influence of Hospital Procedure Volume on Outcomes Following Surgery for Colon Cancer". JAMA. 284 (23): 3028. doi:10.1001/jama.284.23.3028. ISSN 0098-7484.
  • Iasonos, Alexia; Schrag, Deborah; Raj, Ganesh V.; Panageas, Katherine S. (2008-03-10). "How To Build and Interpret a Nomogram for Cancer Prognosis". Journal of Clinical Oncology. 26 (8): 1364–1370. doi:10.1200/JCO.2007.12.9791. ISSN 0732-183X.
  • Basch, Ethan; Deal, Allison M.; Kris, Mark G.; Scher, Howard I.; Hudis, Clifford A.; Sabbatini, Paul; Rogak, Lauren; Bennett, Antonia V.; Dueck, Amylou C.; Atkinson, Thomas M.; Chou, Joanne F.; Dulko, Dorothy; Sit, Laura; Barz, Allison; Novotny, Paul (2016-02-20). "Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial". Journal of Clinical Oncology. 34 (6): 557–565. doi:10.1200/JCO.2015.63.0830. ISSN 0732-183X. PMC 4872028.
  • Schrag, D.; Cramer, L. D.; Bach, P. B.; Begg, C. B. (2001-06-06). "Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer". JNCI Journal of the National Cancer Institute. 93 (11): 850–857. doi:10.1093/jnci/93.11.850. ISSN 0027-8874.

References

edit
  1. ^ "WEDDINGS; Deborah Schrag, Yochai Benkler". The New York Times. 1992-08-23. ISSN 0362-4331. Retrieved 2024-05-24.
  2. ^ "Deb Schrag, MD, MPH, Named Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center". Memorial Sloan Kettering Cancer Center. October 4, 2021. Retrieved 2023-02-09.
  3. ^ "Deb Schrag". Memorial Sloan Kettering Cancer Center. Retrieved 2023-02-09.
  4. ^ Webster, Katherine (1997-05-15). "Early surgery may extend life for women with breast cancer gene". Fort Worth Star-Telegram. p. 10. Retrieved 2024-05-24.
  5. ^ Tanner, Lindsey (2000-02-02). "Study cites pre-emptive breast surgery". The Times-Tribune. p. 7. Retrieved 2024-05-24.
  6. ^ Kolata, Gina (2023-06-04). "Rectal Cancer Patients Could Be Spared the Effects of Radiation". The New York Times. ISSN 0362-4331. Retrieved 2024-05-24.
  7. ^ McLaughlin, Devin; Kunz, Pamela L (June 25, 2023). "Some patients with locally advanced rectal cancer can be spared pelvic radiation". HEM/ONC Today; Thorofare. Vol. 24, no. 9. p. 16 – via Proquest.
edit